ICU Medical Trading Down 6.2% Following Analyst Downgrade (ICUI)
ICU Medical (NASDAQ:ICUI) traded down 6.2% during trading on Friday after Roth Capital lowered their price target on the stock from $62.00 to $56.00, Analyst Ratings Net reports. The stock traded as low as $58.08 and last traded at $59.03, with a volume of 540,532 shares changing hands. The stock had previously closed at $62.92.
Separately, analysts at Zacks upgraded shares of ICU Medical from an “underperform” rating to a “neutral” rating in a research note on Tuesday, December 24th. They now have a $65.60 price target on the stock. Five investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $66.32.
The stock’s 50-day moving average is $63.68 and its 200-day moving average is $66.00. The company has a market cap of $887.2 million and a P/E ratio of 23.74.
ICU Medical (NASDAQ:ICUI) last released its earnings data on Wednesday, February 12th. The company reported $0.86 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.73 by $0.13. The company had revenue of $77.90 million for the quarter, compared to the consensus estimate of $84.25 million. During the same quarter in the prior year, the company posted $0.82 earnings per share. The company’s quarterly revenue was down 5.8% on a year-over-year basis. On average, analysts predict that ICU Medical will post $2.62 earnings per share for the current fiscal year.
Manufactures custom-made IV products, such as a click-lock positive connection device, and its accessories.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.